TA174 Leukaemia (chronic lymphocytic, first line) - rituximab: guidance (MS Word format)
|
TA174 Leukaemia (chronic lymphocytic, first line) - rituximab: guidance (MS Word format)
22 July 2009 (606.5 Kb 2 mins 56 sec) |
